S100B as marker of brain damage
DOI:
https://doi.org/10.25305/unj.88757Keywords:
brain, damage, diagnostics, protein of S100BAbstract
The estimation of S100B protein concentration at late time is included to most widespread methods of estimation of brain injury heaviness at neurosurgical and neurological diseases. Of S100B concentration increase in plasma and cerebrospinal fluid is related to microglia activation — the early response of cerebral fabric on damage. S100B level estimation has low specificity, but high sensitiveness for brain damage determination. A change of it’s concentration takes place at intracerebral hemorrhage and ischemic stroke, brain tumors, psychiatric diseases, traumatic brain injury. Protein level measuring in a dynamics gives important information about efficiency of treatment of brain pathology, possible relapse of disease, prognosis.References
S100B protein regulates astrocyte shape and migration via interaction with src kinase: Implications for astrocyte development, activation, and tumor growth / F.Brozzi, C.Arcuri, I.Giambanco [et al.] // J. Biol. Chem. — 2009. — V.284, N13. — P.8797–8811.
S100B’s double life: intracellular regulator and extracellular signal / R.Donato, G.Sorci, F.Riuzzi [et al.] // Biochim. Biophys. Acta. — 2009. — V.1793, N6. — P.1008–1022.
Brain injury marker S100B can reduce the use of computer tomography in minor head injuries--secondary publication / J.B.Springborg, J.Undén, T.Ingebrigtsen [et al.] // Ugeskr. Laeger. — 2009. — V.171, N.12. — P.978–981.
Cerebrospinal s100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury / C.Kirchhoff, S.Buhmann, V.Braunstein [et al.] // Eur. J. Med. Res. — 2008. — V.13, N11. — P.511–516.
Serum S100B, brain edema, and hematoma formation in a rat model of collagenase-induced hemorrhagic stroke / Y.Tanaka, T.Marumo, H.Shibuta [et al.] // Brain Res. Bull. — 2009. — V.78, N4–5. — P.158–163.
Dassan P. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B / P.Dassan, G.Keir, M.M.Brown // Cerebrovasc. Dis. — 2009. — V.27, N3. — P.295–302.
Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke / R.S.Kashyap, A.R.Nayak, P.S.Deshpande [et al.] // Clin. Chim. Acta. — 2009. — V.402, N1–2. — P.160–163.
Predictive value of selected biochemical markers of brain damage for functional outcome in ischemic stroke patients / H.Sienkiewicz-Jarosz, M.Gaecka-Wolska, A.Bidziski [et al.] // Neurol. Neurochir. Pol. — 2009. — V.43, N2. — P.126–133.
Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation / J.Undn, K.Strandberg, J.Malm [et al.] // J. Neurol. — 2009. — V.256, N.1. — P.72–77.
Simvastatin inhibits the increase in serum tau protein levels in the acute phase of ischemic stroke / J.Kurzepa, J.Bielewicz, H.Bartosik-Psujek [et al.] // Pharmacol. Rep. — 2008. — V.60, N6. — P.1014–1018.
Brain Study Group. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study / D.T.Laskowitz, S.E.Kasner, J.Saver [et al.] // Stroke. — 2009. — V.40, N.1. — P.77–85.
Caffeic acid phenethyl ester decreases the level of S-100B protein after middle cerebral artery [correction for after] occlusion in rabbits / Y.Serarslan, R.Bal, M.E.Altu [et al.] // Pak. J. Pharm. Sci. — 2009. — V.22, N3. — P.313–316.
Jugular venous neurone specific enolase (NSE) increases following carotid endarterectomy under general, but not local, anaesthesia / S.Wijeyaratne, M.Collins, J.Barth [et al.] // Eur. J. Vasc. Endovasc. Surg. — 2009. — V.38, N3. — P.262–266.
Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function / O.A.Gressner, M.C.Schifflers, P.Kim [et al.] // Clin. Chim. Acta. — 2009. — V.400, N1–2. — P.86–90.
S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage / P.Sanchez-Peña, A.R.Pereira, N.A.Sourour [et al.] // Crit. Care Med. — 2008. —V.36, N8. — P.2267–2273.
Can serum protein S100beta predict neurological deterioration after moderate or minor traumatic brain injury? / P.Bouzat, G.Francony, P. Declety [et al.] // Ann. Fr. Anesth. Reanim. — 2009. — V.28, N2. — P.135–139.
Prediction of time trends in recovery of cognitive function after mild head injury / K.Mller, T.Ingebrigtsen, T.Wilsgaard [et al.] // Neurosurgery. — 2009. — V.64, N4. — P.698–704.
Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point / T.Rainey, M.Lesko, R.Sacho [et al.] // Resuscitation. — 2009. — V.80, N3. — P.341–345.
Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression / R.D.Gosselin, S.Gibney, D.O’Malley [et al.] // Neuroscience. — 2009. — V.159, N2. — P.915–925.
Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice / O.Schulte-Herbrggen, H.Hrtnagl, G.Ponath [et al.] // Neurosci. Lett. — 2008. — V.442, N2. — P.100–103.
The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression / K.Yang, G.Xie, Y.Hu [et al.] // J. Neural. Transm. — 2008. — V.115, N12. — P.1687–1694.
Circulating cerebral S100B protein is associated with depressive symptoms following myocardial infarction / D.M.Tulner, O.R.Smith, P.de Jonge [et al.] // Neuropsychobiology. — 2009. — V.59, N2. — P.87–95.
Astroglial and cognitive effects of chronic cerebral hypoperfusion in the rat / E.Vicente, D.Degerone, L.Bohn [et al.] // Brain Res. — 2009. — V.28, N1251. — P.204–212.
Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia — original research and meta-analysis / M.L.Schroeter, H.Abdul-Khaliq, M.Krebs [et al.] // Psychiatry Res. — 2009. — V.167, N1–2. — P.66–72.
Serum concentrations of s100b and NSE in migraine / M.Teepker, K.Munk, V.Mylius [et al.] // Headache. — 2009. — V.49, N2. — P.245–252.
Diffuse intracranial oligodendroglioma in a cow / S.Kleinschmidt, K.Herzog, L.Krger [et al.] // J. Comp. Pathol. — 2009. — 140, N1. — P.72–75.
Tunici P. Pituitary adenoma stem cells / P.Tunici, J.S.Yu // Methods Mol. Biol. — 2009. — V.568. — P.195–201.
Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury / D.Gazzolo, R.Abella, E.Marinoni [et al.] // Cardiovasc. Hematol. Agents Med. Chem. — 2009. — V.7, N2. — P.108–126.
Perinatal asphyxia in preterm neonates leads to serum changes in protein S-100 and neuron specific enolase / D.Giuseppe, C.Sergio, B.Pasqua [et al.] // Curr. Neurovasc. Res. — 2009. — V.6, N2. — P.110–116.
Amniotic fluid S100B protein and erythropoietin in pregnancies at risk for fetal hypoxia / M.Loukovaara, K.Teramo, H.Alfthan [et al.] // Eur. J. Obstet. Gynec. Reprod. Biol. — 2009. — V.142, N2. — P.115–118.
Tau and S100B proteins as biochemical markers of bilirubin-induced neurotoxicity in term neonates / N.Okumus, C.Turkyilmaz, E.Onal [et al.] // Pediatr. Neurol. — 2008. — V.39, N4. — P.245–252.
Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes / Y.V.Lebed, M.A.Orlovsky, A.G.Nikonenko [et al.] // Neurosci. Lett. — 2008. — V.444, N2. — P.181–185.
Sepsis associated encephalopathy studied by MRI and cerebral spinal fluid S100B measurement / O.Piazza, S.Cotena, E.De Robertis [et al.] // Neurochem. Res. — 2009. — V.34, N7. — P.1289–1292.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2010 S. A. Dudukina, Yu. Yu. Kobelyatskiy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
